Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants

Bibliographic Details
Title: Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants
Authors: Suvimol Niyomnaitham, Anan Jongkaewwattana, Atibordee Meesing, Nawamin Pinpathomrat, Sira Nanthapisal, Nattiya Hirankarn, Sarawut Siwamogsatham, Suppachok Kirdlarp, Romanee Chaiwarith, Saranath Lawpoolsri, Supranee Phanthanawiboon, Arunee Thitithanyanont, Pokrath Hansasuta, Sansanee Chaiyaroj, Punnee Pitisuttithum
Source: International Journal of Infectious Diseases, Vol 129, Iss , Pp 19-31 (2023)
Publisher Information: Elsevier, 2023.
Publication Year: 2023
Collection: LCC:Infectious and parasitic diseases
Subject Terms: Immune response, COVID-19, Vaccine, Booster strategy, Infectious and parasitic diseases, RC109-216
More Details: Objectives: The study aimed to compare the immunogenicity and safety of fractional (half) third doses of heterologous COVID-19 vaccines (AZD1222 or BNT162b2) to full doses after the two-dose CoronaVac and when boosting after three different extended intervals. Methods: At 60-
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1201-9712
38907437
Relation: http://www.sciencedirect.com/science/article/pii/S1201971223000218; https://doaj.org/toc/1201-9712
DOI: 10.1016/j.ijid.2023.01.022
Access URL: https://doaj.org/article/5c389074371f4ee3b9b88a004a527f2d
Accession Number: edsdoj.5c389074371f4ee3b9b88a004a527f2d
Database: Directory of Open Access Journals
More Details
ISSN:12019712
38907437
DOI:10.1016/j.ijid.2023.01.022
Published in:International Journal of Infectious Diseases
Language:English